Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats.
The effects of Klebsiella pneumoniae O3 lipopolysaccharide on the renal handling and distribution characteristics of the aminoglycoside tobramycin were investigated in rats. Tobramycin (2 mg kg-1) and inulin (100 mg kg-1) were administered intravenously 2 h after administration of 50, 250 or 500 micrograms kg-1 lipopolysaccharide. Lipopolysaccharide delayed the disappearance of tobramycin from plasma in a dose-dependent manner. A dose-dependent decrease in systemic clearance of tobramycin was observed, although the elimination rate constant and fraction of urinary recovery of unchanged drug were not significantly different in any group. Lipopolysaccharide significantly decreased the central compartment volume of distribution of tobramycin, but did not influence the steady-state volume of distribution. A dose-related increase in the ratio of the rate constant of transfer to the peripheral compartment to the rate constant of transfer from peripheral compartment to central compartment was observed. The glomerular filtration rate was significantly decreased by pretreatment with 250 micrograms kg-1 lipopolysaccharide and the clearance ratio was decreased by 20%, indicating that lipopolysaccharide increases the tubular reabsorption of tobramycin. Our findings suggest that K. pneumoniae O3 lipopolysaccharide modifies the glomerular filtration rate and tubular reabsorption without change in the terminal half-life and that drug distribution characteristics from the rapidly-distributing compartment to the peripheral compartment were altered without expansion of the extracellular fluid volume.
Nadai
M
M
Department of Hospital Pharmacy, Nagoya University School of Medicine, Japan.
Hasegawa
T
T
Kato
K
K
Wang
L
L
Nabeshima
T
T
Kato
N
N
D000818:Animals; D005919:Glomerular Filtration Rate; D007275:Injections, Intravenous; D007711:Klebsiella pneumoniae; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D014031:Tobramycin / Q000493:pharmacokinetics* / Q000652:urine
D008070:Lipopolysaccharides; D014031:Tobramycin